Clinical features, imaging use, and management in giant cell arteritis: a retrospective single-center study
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-07078-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Aradhna Agarwal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, UT Southwestern Medical Center, Dallas, USA. aradhna.agarwal92@gmail.com. Hauptthemen laut MEDLINE: Giant Cell Arteritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Office of Academic Affiliations, Department of Veterans Affairs.
Abstract (Originalsprache)
This study examines the characteristics of patients with giant cell arteritis (GCA), the utilization of imaging in GCA diagnosis, and variations in GCA management among specialties. Subjects were identified from the Dallas VAMC database spanning 2010 to 2021 using ICD-9/10 codes for GCA and polymyalgia rheumatica, and a list of temporal artery biopsies (TAB). Patients lacking sufficient data to meet the ACR 1990 classification criteria for GCA were excluded. Categorical variables were compared using Fisher's exact test. Continuous variables were analyzed with the Kruskal-Wallis test. Among 209 identified patients, 41 were excluded due to insufficient data for ACR classification. The cohort comprised 91.9% males with a median age of 69. Of the remaining 168 patients, 42 received a final diagnosis of GCA, and 15 of these were confirmed with a positive TAB. The most reported initial symptoms were visual disturbances (75.5%) and headaches (67.7%). Ophthalmology was the initial physician for 46% of patients. GCA correlated with co-existing autoimmune diseases, glucocorticoid-sparing treatments, and consultation with a rheumatologist (p < 0.05). There were no significant differences in clinical features or management of the positive and negative TAB GCA groups. GCA presents with heterogeneous symptoms making diagnosis challenging. Scalp tenderness and headaches were significantly higher in GCA patients, but sub-group analysis revealed no significant differences among GCA patients. Vascular assessments and adjunct imaging modalities are underutilized. The establishment of multidisciplinary or fast-track clinics may enhance the optimization of GCA management. Key Points • The most common presenting symptoms were blurry vision/visual loss (75.5%), headache (67.7%), and scalp tenderness (35.9%) in descending order. • In sub-group analysis, no significant differences were found between GCA sub-groups, but when compared to the non-GCA group, were found to have significantly higher rates of headache and scalp tenderness. • Compared to other specialties, rheumatologists were more likely to use advanced imaging, and to prescribe glucocorticoid-sparing treatments. • Systematic and comprehensive assessment and multidisciplinary approach could improve diagnosis and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine, UT Southwestern Medical Center, Dallas, USA. aradhna.agarwal92@gmail.com.
- Internal Medicine, UT Southwestern Medical Center, Dallas, USA.
- Rheumatology Section, VA North Texas Health Care System, Dallas, USA.
- University of Texas Southwestern Medical Center, Dallas, USA.
Förderung
- Office of Academic Affiliations, Department of Veterans Affairs
Zitieren
APA
Agarwal, A., Weisberg, R., Mathew, J., Reimold, A., & Shwin, K. (2024). Clinical features, imaging use, and management in giant cell arteritis: a retrospective single-center study. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07078-0
Vancouver
Agarwal A, Weisberg R, Mathew J, Reimold A, Shwin K. Clinical features, imaging use, and management in giant cell arteritis: a retrospective single-center study. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07078-0
BibTeX
@article{Agarwal2024,
author = {Agarwal, Aradhna and Weisberg, Reid and Mathew, Jiby and Reimold, Andreas and Shwin, Kyawt},
title = {Clinical features, imaging use, and management in giant cell arteritis: a retrospective single-center study},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-07078-0}
}
EUVIMED